Ocugen, Inc. — Director's Dealing 2019

Feb 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HISTOGENICS CORP (HSGX)
CIK: 0001372299
Period of Report: 2019-02-08

Reporting Person: Wilmslow Estates Ltd (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-08	Common Stock	M	403845	—	Acquired	4014415	Direct
2019-02-08	Common Stock	M	1244444	—	Acquired	5258859	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-08	Common Stock Warrant (Right to Buy)	$0.01	M	403845	Acquired	2023-10-10	Common Stock (403845)	Direct
2019-02-08	Common Stock Warrant (Right to Buy)	$0.01	M	1244444	Acquired	2021-11-22	Common Stock (1244444)	Direct

Footnotes

F1: The per share exercise price of each Common Stock Warrant was re-priced to $0.01 pursuant to a warrant exercise agreement entered into with the Issuer on February 8, 2019.